PT Royal Prima Tbk (PRIM.JK)
IDR 57.0
(0.0%)
IDR 57.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 49.68 Billion IDR | -4.2% |
| 2022 | 51.86 Billion IDR | -68.97% |
| 2021 | 167.11 Billion IDR | 174.17% |
| 2020 | 60.95 Billion IDR | 0.95% |
| 2019 | 60.37 Billion IDR | -4.81% |
| 2018 | 63.42 Billion IDR | 7.11% |
| 2017 | 59.21 Billion IDR | 126.6% |
| 2016 | 26.13 Billion IDR | -0.95% |
| 2015 | 26.38 Billion IDR | 89.58% |
| 2014 | 13.91 Billion IDR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 52.62 Billion IDR | 5.92% |
| 2024 Q2 | 55.67 Billion IDR | 5.79% |
| 2024 Q3 | 113.01 Billion IDR | 103.0% |
| 2023 Q4 | 49.68 Billion IDR | -1.36% |
| 2023 Q3 | 50.37 Billion IDR | 8.87% |
| 2023 FY | 49.68 Billion IDR | -4.2% |
| 2023 Q2 | 46.26 Billion IDR | -14.83% |
| 2023 Q1 | 54.32 Billion IDR | 4.75% |
| 2022 Q2 | 76.04 Billion IDR | 3.26% |
| 2022 Q3 | 57.38 Billion IDR | -24.53% |
| 2022 FY | 51.86 Billion IDR | -68.97% |
| 2022 Q4 | 51.86 Billion IDR | -9.63% |
| 2022 Q1 | 73.64 Billion IDR | -55.93% |
| 2021 Q2 | 180.39 Billion IDR | 108.43% |
| 2021 Q4 | 167.11 Billion IDR | -4.73% |
| 2021 Q3 | 175.41 Billion IDR | -2.76% |
| 2021 Q1 | 86.55 Billion IDR | 42.0% |
| 2021 FY | 167.11 Billion IDR | 174.17% |
| 2020 FY | 60.95 Billion IDR | 0.95% |
| 2020 Q2 | 43.39 Billion IDR | -21.5% |
| 2020 Q3 | 41.83 Billion IDR | -3.61% |
| 2020 Q4 | 60.95 Billion IDR | 45.7% |
| 2020 Q1 | 55.28 Billion IDR | -8.43% |
| 2019 Q3 | 73.46 Billion IDR | 28.09% |
| 2019 FY | 60.37 Billion IDR | -4.81% |
| 2019 Q1 | 57.93 Billion IDR | -8.66% |
| 2019 Q4 | 60.37 Billion IDR | -17.81% |
| 2019 Q2 | 57.35 Billion IDR | -1.01% |
| 2018 Q3 | 50.73 Billion IDR | 1.78% |
| 2018 FY | 63.42 Billion IDR | 7.11% |
| 2018 Q4 | 63.42 Billion IDR | 25.02% |
| 2018 Q2 | 49.84 Billion IDR | 0.0% |
| 2018 Q1 | - IDR | -100.0% |
| 2017 Q1 | - IDR | 0.0% |
| 2017 Q4 | 50.83 Billion IDR | 0.0% |
| 2017 FY | 59.21 Billion IDR | 126.6% |
| 2016 FY | 26.13 Billion IDR | -0.95% |
| 2015 FY | 26.38 Billion IDR | 89.58% |
| 2014 FY | 13.91 Billion IDR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| PT Bundamedik Tbk | 1283.12 Billion IDR | 96.128% |
| PT Metro Healthcare Indonesia Tbk | 1039.28 Billion IDR | 95.219% |
| PT Medikaloka Hermina Tbk | 3604.32 Billion IDR | 98.622% |
| PT Mitra Keluarga Karyasehat Tbk | 741.05 Billion IDR | 93.295% |
| PT Murni Sadar Tbk | 708.74 Billion IDR | 92.99% |
| PT Famon Awal Bros Sedaya Tbk | 1769.45 Billion IDR | 97.192% |
| PT Kedoya Adyaraya Tbk | 77.63 Billion IDR | 36.0% |
| PT Sarana Meditama Metropolitan Tbk | 1381.15 Billion IDR | 96.403% |
| PT Siloam International Hospitals Tbk | 2934.42 Billion IDR | 98.307% |
| PT Sejahteraraya Anugrahjaya Tbk | 3748.83 Billion IDR | 98.675% |